172. Rogers J. S. Hypercoagulable states // W. V. Med. J. - 1993. - Feb, 89:2, 61-3.
173. Rosenberg I. L., Evans M., Pollock A. V. Prophylaxis of postoperative leg vein thrombosis by low dose subcutaneous heparin or preoperative calf muscle stimulation. A controlled clinical trial // Brit. Med. J. – 1975. - Vol. 1. - P. 649 - 651.
174. Saizman E. W. Low molecular weight heparin and other new antithrombotic drugs // New. Engl. J. Med. - 1992. - Vol.326. - P. 1017 - 1019.
175. Sakariassen K. S., Barstad R. M. Mechanisms of thromboembolism at arterial plaques // Blood. Coagul. Fibrinolysis. – 1993. - Aug, 4:4, 615 – 25.
176. Sakata T., Kario K., Katayama Y., Matsuyama T., Kato H., Miyata T. Clinical significance of activated protein C resistance as a potential marker for hypercoagulable state // Thromb Res. – 1996. - May, 82:3, 235 – 44.
177. Sallah S. Inhibitors to clotting factors // Ann. Hematol. – 1997. - Jul, 75:1-2, 1 – 7.
178. Schini V. В., Hendricks H., Heublein D. М. et al. Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells // Europ. J. Pharmacol. - 1989. - Vol. 165. - № 2 - 3. - P. 333 - 334.
179. Schleef R. R., Loskutoff D. I. Fibrinolytic system of vascular endothelial cells. Role of plasminogen activator inhibitors // Haemostasis. - 1988. - Vol. 18. - № 4. - P. 328 - 341.
180. Scrobohaci M. L., Freyssinet J. M. Antiphospholipid antibodies – antiphospholipid syndrome. Cause or consequence of thrombosis // Pathol. Biol. (Paris). – 1991. - Sep, 39:7, 709 – 15.
181. Sharnoff J. G. Result in the prophylaxis of postoperative thromboembolism // Surg. Gynec. Obstet. - 1966. - Vol. 123. - P. 303 - 307.
182. Spillert C. R., Lazaro E. J. Modified recalcification time (MRT): a sensitive cancer test? // J. Natl. Med. Assoc. – 1995. - Sep, 87:9, 687 – 92.
183. Spillert C. R., Lazaro E. J. Modified recalcification time: a global coagulation screening test // J. Natl. Med. Assoc. – 1993. - Aug, 85:8, 611 – 6.
184. Takeya H., Suzuki K. Anticoagulant and fibrinolytic systems of the injured vascular endothelial cells // Rinsho Byori. – 1994. - Apr, 42:4, 333 – 9.
185. Tatewaki H., Iida H., Nakahara M., Tsuda H., Kinoshita S., Kanaji T., et al. A novel splice acceptor site mutation which produces multiple splicing abnormalities resulting in protein S deficiency type I // Thromb Haemost – 1999. 82:65-71.
186. Thomas D. P., Roberts H. R. Hypercoagulability in venous and arterial thrombosis // Ann. Intern. Med. – 1997. - Apr, 126:8, 638 – 44.
187. Tomoda H. Plasma endothelin-1 in acute myocardial infarction // Am-Heart-J. - 1993. – Mar, 125(3) 667 - 72.
188. Tsuda H., Urata M., Tsuda T., Wakiyama M., Iida H., Nakahara M., et al. Four missense mutations identified in the protein S gene of thrombosis patients with protein S deficiency. Effects on secretion and anticoagulant activity of protein S // Thromb Res – 2002. - 105:233-9.
189. Vaarala O. Antiphospholipid antibodies and atherosclerosis // Lupus. – 1996. - Oct, 5:5, 442 – 7.
190. Vane I. R., Anggard E. E., Botting R. М. et al. Regulatory functions of the vascular endothelium // New. Engl. J. Med. - 1990. - Vol. 323. - P. 27 - 34.
191. Villoutreix B. O., Dahlback B., Borgel D., Gandrille S., Muller Y. A. Three-dimensional model of the SHBG-like region of anticoagulant protein S: new structure-function insights // Proteins – 2001. - 43:203-16.
192. Webb J. H., Blom A. M., Dahlback B. Vitamin K-dependent protein S localizing complement regulator C4b-binding protein to the surface of apoptotic cells // J Immunol – 2002. - 169:2580-86.
193. Weinmann E. E., Saizman E. W. Medical Progress: deep vein thrombosis // New. Engl. J. Med. - 1994. - Vol. 331. - № 24.- P. 1630 - 1642.
194. Weitz J. I. Activation of blood coagulation by plaque rupture: mechanisms and prevention // Am. J. Cardiol. – 1995. - Feb, 75:6, 18B - 22B.
195. Wells P. S., Lensing A. W.A., Hirsh J. Graduated compression stockings in the prevention of postoperative venous thromboembolism. A meta-analysis // Arch. intern. Med. – 1994. - Vol. 154. - № 1. - P. 67 - 72.
196. Wiesel M. L., Charmantier J. L., Freyssinet J. M., Grunebaum L., Schuhler S., Cazenave J. P. Screening of protein S deficiency using a functional assay in patients with venous and arterial thrombosis // Thromb. Res. – 1990. – Jun, 1, 58:5, 461 – 8.
197. Wiig J. N., Solhaug J. H., Bilberg T. et al. Prophylaxis of veno-graphically diagnosed deep vein thrombosis in gastrointestinal surgery // Europ. rg. -1995. - Vol. 161. - № 5. - P. 663 - 668.
198. Wille-Jorgensen P., Hauch 0., Dimo B. et al. Prophylaxis of deep venous thrombosis after acute abdominal operation // Surg. Gynec. Obstet. - 1991. - Vol. 172. - № 1. - P. 44 - 48.
199. Wille-Jorgensen P. Prophylaxis of postoperative thromboembolism // Copenhagen: Lageforeningens Forlag. - 1991.
200. Wolfe W. G., Sabiston D. C.Jr. Pulmonary Embolism // Philadelphia: Sannders. – 1980. – P. 180.
201. Wuillemin W. A., Hack C. E., Bleeker W. K., Biemond B. J., Levi M., Cate H. Inactivation of factor Xia in vivo: studies in chimpanzees and in humans // Thromb. Haemost. – 1996. – Oct, 76(4):549 – 55.
202. Yamamoto J., Ishii I., Okada Y., Yamashita T., Ridler C. D., Gorog P., Kovacs I. B. Effect of leucocyte products on platelet thrombus formation, coagulation and spontaneous thrombolysis, as measured from native human blood, in vitro // Thromb. Res. – 1993. – Aug, 15, 71:4, 281 – 7.
203. Yamazaki T., Saito H., Dahlback B. Rapid intracellular degradation of a truncated mutant protein S (Q522X) // Thromb Haemost – 2002. - 87:171-2.
204. Yin E. T., Wessler S. Heparin accelerated inhibition of activated factor by a natural plasma inhibitor // Biochim. biophys. Acta. - 1970. - Vol. 201. - № 2. - P. 387 - 390.
205. Zerbino D. D., Lukasevich L. L., Servetnik M. I. Thrombosis and embolism as paraneoplastic syndrome // Arkh. Patol. - 1994. - Jul, 56:4, 77 - 80.
|
Из за большого объема этот материал размещен на нескольких страницах:
1 2 3 4 5 6 |
